EAU 2014 - Results from #20

EAU 2014 - Effects of prior use of statins in a phase 3 study of intermittent versus continuous combined androgen deprivation - Session Highlights April 15, 2014

EAU 2014 - Nadir testosterone on ADT predicts for time to castrate resistant progression: A secondary analysis of the PR-7 intermittent vs continuous ADT trial - Session Highlights April 15, 2014

EAU 2014 - Long-term immunotherapy by dendritic-cells based vaccine in patients with PSA-recurrent prostate cancer - Session Highlights April 15, 2014

EAU 2014 - Prevention of symptomatic skeletal events in patients with genitourinary (GU) tumours and bone metastases treated with denosumab or zoledronic acid - Session Highlights April 15, 2014

EAU 2014 - Does Gleason score at initial diagnosis predict efficacy of abiraterone acetate (AA) therapy in patients with metastatic castration-resistant prostate cancer (mCRPC)? An analysis of AA phase 3 trials - Session Highlights April 15, 2014

EAU 2014 - Low dose GTx-758 decreases free testosterone to levels similar to orchiectomy in men with metastatic castration resistant prostate cancer (mCRPC) - Session Highlights April 15, 2014

EAU 2014 - Impact of prior endocrine therapy on radiographic progression-free survival (rPFS) in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer: Results from COU-AA-302 - Session Highlights April 15, 2014

EAU 2014 - Predicting targeted therapy tumor resistance in renal cell carcinoma patient-derived xenografts implanted into chicken embryos - Session Highlights April 15, 2014

EAU 2014 - Overall survival benefit of partial over radical nephrectomy in patients presenting with renal cell carcinoma - Session Highlights April 15, 2014

EAU 2014 - Infiltration of CD3+ and CD68+ cells in bladder cancer is subtype specific and affects outcome of patients with muscle-invasive tumors - Session Highlights April 15, 2014

EAU 2014 - Occult lymph node metastases in patients with muscle invasive bladder cancer: Incidence after neoadjuvant chemotherapy and cystectomy versus cystectomy alone - Session Highlights April 15, 2014

EAU 2014 - A randomized, double blind, placebo controlled phase II trial to evaluate the safety and efficacy of recMAGE-A3 + AS15 antigen specific cancer immunotherapy in patients with MAGE-A3 positive muscle invasive bladder cancer after cystectomy... April 15, 2014

EAU 2014 - Survival benefit of radical prostatectomy in patients with clinically advanced prostate cancer: Estimations of the number needed to treat based on competing-risks analysis - Session Highlights April 14, 2014

EAU 2014 - Is the striated urethral sphincter at risk by standard suture ligation of the dorsal vein complex in radical prostatectomy? An anatomical study in adult human male cadavers - Session Highlights April 14, 2014

EAU 2014 - Early start of oral sildenafil 100mg for erectile dysfunction after robotic assisted laparoscopic radical prostatectomy: Preliminary results from randomized prospective trial - Session Highlights April 14, 2014

EAU 2014 - A prospective comparison of transrectal ultrasound biopsy with an MRI based diagnostic strategy in men with suspicion of prostate cancer - Session Highlights April 14, 2014

EAU 2014 - Role of repeat 3T multiparametric MR imaging and MR-guided biopsy versus repeat TRUS-guided biopsies after 1 year follow-up in low-risk prostate cancer patients in an active surveillance protocol - Session Highlights April 14, 2014

EAU 2014 - Multicentre experience of uptake of renal tumour biopsies for small renal masses - Session Highlights April 14, 2014

EAU 2014 - T1a patients with metastatic RCC at diagnosis markedly differ from patients who present with localized malignant SRMs - Session Highlights April 14, 2014

EAU 2014 - State-of-the-art lecture: Late morbidity in testicular cancer - Session Highlights April 14, 2014

Page 2 of 4